This company seems to have been delisted
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Reason: Filed for bankruptcy
Last recorded trade on: October 20, 2023
Source: https://www.reuters.com/business/biotech-firm-amyris-files-bankruptcy-us-2023-08-10/
Amyris
AMRS
₹4.29
Share price
0.00%
Change (1 day)
-97.14%
Change (1 year)
EPS for Amyris (AMRS)
EPS in 2023 (TTM): -₹149.14
According to Amyris's latest financial reports the company's current EPS (TTM) is -₹157.18. In 2022 the company made an earnings per share (EPS) of -₹140.86 a decrease over its 2021 EPS that were of -₹85.89.
EPS history for Amyris from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -₹149.14 | 5.88% |
| 2022 | -₹140.86 | 64% |
| 2021 | -₹85.89 | -48.19% |
| 2020 | -₹165.77 | -30.82% |
| 2019 | -₹239.63 | -22.28% |
| 2018 | -₹308.35 | -2.45% |
| 2017 | -₹316.08 | -29.9% |
| 2016 | -₹450.92 | -82.76% |
| 2015 | -₹2,615 | -6866.68% |
| 2014 | ₹38.65 | -100.97% |
| 2013 | -₹3,994 | -17.33% |
| 2012 | -₹4,831 | -6.02% |
| 2011 | -₹5,140 | -79.68% |
| 2010 | -₹25,296 | 49.59% |
| 2009 | -₹16,911 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | -₹731.78 | 365.57% | 🇺🇸 USA |
 | ₹2,436 | -1,649.73% | 🇺🇸 USA |
 | ₹81.60 | -151.91% | 🇺🇸 USA |
 | -₹203.56 | 29.51% | 🇺🇸 USA |
 | -₹36.93 | -76.50% | 🇺🇸 USA |
 | ₹832.27 | -629.51% | 🇺🇸 USA |